A2Z Smart Technologies Corp.
(NASDAQ: AZ) |
$0.431 |
$21.29M |
+5.23% |
Aadi Bioscience Inc.
(NASDAQ: AADI) |
$1.860 |
$45.67M |
+6.29% |
Abeona Therapeutics Inc.
(NASDAQ: ABEO) |
$3.440 |
$94.10M |
+5.83% |
Abits Group Inc
(NASDAQ: ABTS) |
$0.742 |
$28.07M |
0% |
Able View Global Inc.
(NASDAQ: ABLV) |
$1.420 |
$59.47M |
-6.92% |
abrdn Asia-Pacific Income Fund Inc.
(NYSE American: FAX) |
$2.520 |
$624.19M |
-1.56% |
abrdn Australia Equity Fund Inc.
(NYSE American: IAF) |
$4.285 |
$114.05M |
+1.90% |
abrdn Global Income Fund Inc.
(NYSE American: FCO) |
$5.550 |
$74.43M |
-0.72% |
abrdn National Municipal Income Fund
(NYSE American: VFL) |
$9.930 |
$121.86M |
+0.15% |
ABVC BioPharma Inc.
(NASDAQ: ABVC) |
$1.400 |
$14.78M |
-1.41% |
AC Immune SA
(NASDAQ: ACIU) |
$2.406 |
$237.36M |
+3.40% |
Acasti Pharma Inc.
(NASDAQ: ACST) |
$2.680 |
$25.19M |
0% |
Accelerate Diagnostics Inc.
(NASDAQ: AXDX) |
$0.923 |
$19.99M |
0% |
Accuray Incorporated
(NASDAQ: ARAY) |
$2.220 |
$220.15M |
+1.14% |
Ace Global Business Acquisition Limited
(NASDAQ: ACBA) |
$12.161 |
$41.48M |
0% |
Achieve Life Sciences Inc.
(NASDAQ: ACHV) |
$4.571 |
$156.53M |
-0.87% |
Achilles Therapeutics
(NASDAQ: ACHL) |
$0.760 |
$31.54M |
+0.01% |
Aclarion Inc.
(NASDAQ: ACON) |
$0.298 |
$2.13M |
-10.09% |
Aclaris Therapeutics Inc.
(NASDAQ: ACRS) |
$1.220 |
$86.53M |
+1.25% |
Acme United Corporation.
(NYSE American: ACU) |
$40.674 |
$148.91M |
-1.03% |